N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model

Neuroscience Research

Volumn 64, Issue 3, 2009, Pages 267-272

  Luszczki, Jarogniew J ^a,b   Kocharov, Sergey L ^c   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Armenia)

Author keywords

Antiepileptic drugs; Maximal electroshock induced seizures; Pharmacokinetic pharmacodynamic interaction; Succinimide derivative

Indexed keywords

CARBAMAZEPINE; N (ANILINOMETHYL) PARA ISOPROPOXYPHENYLSUCCINIMIDE; PHENOBARBITAL; PHENYTOIN; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG POTENTIATION; GRIP STRENGTH; LONG TERM MEMORY; MALE; MOTOR COORDINATION; MOUSE; MUSCLE STRENGTH; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE;

ANILINE COMPOUNDS; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MEMORY; MICE; MODELS, ANIMAL; MOTOR ACTIVITY; MUSCLE STRENGTH; PHENOBARBITAL; PHENYTOIN; SEIZURES; SUCCINIMIDES; VALPROIC ACID;

EID: 67349284659     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.03.010     Document Type: Article

References (25)

1. Boissier J.R., Tardy J., and Diverres J.C. Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée. Med. Exp. (Basel) 3 (1960) 81-84
2. Brodie M.J., and Schachter S.C. Fast Facts. Epilepsy. second ed. (2001), Health Press, Oxford p. 84
3. Cadart M., Marchand S., Pariat C., Bouquet S., and Couet W. Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm. Res. 19 (2002) 209-214
4. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr. Top. Med. Chem. 5 (2005) 3-14
5. Deckers C.L., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P., Renier W.O., and van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed. Epilepsia 41 (2000) 1364-1374
6. Kaminski K., and Obniska J. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)-3-substituted pyrrolidine-2,5-dione derivatives. Acta Pol. Pharm. 65 (2008) 457-465
7. Ko G.Y., Brown-Croyts L.M., and Teyler T.J. The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus. Brain Res. Bull. 42 (1997) 297-302
8. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 342 (2000) 314-319
9. Kwan P., and Brodie M.J. Epilepsy after the first drug fails: substitution or add-on?. Seizure 9 (2000) 464-468
10. Lange J., Rump S., Galecka E., Ilczuk I., Lechowska-Postek M., and Rabsztyn T. Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 32 (1977) 82-84
11. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
12. Löscher W., and Fiedler M. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures. Epilepsy Res. 38 (2000) 231-248
13. Löscher W., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 8 (1991) 79-94
14. Luszczki J.J., Swiader M., Parada-Turska J., and Czuczwar S.J. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology 28 (2003) 1817-1830
15. Luszczki J.J., Swiader M., Czuczwar M., Kis J., and Czuczwar S.J. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol. Biochem. Behav. 75 (2003) 319-327
16. Luszczki J.J., Wojcik-Cwikla J., Andres M.M., and Czuczwar S.J. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 30 (2005) 958-973
17. Luszczki J.J., Ratnaraj N., Patsalos P.N., and Czuczwar S.J. Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn-Schmiedeberg's Arch. Pharmacol. 373 (2006) 169-181
18. Luszczki J.J., Sawicka K.M., Kozinska J., Borowicz K.K., and Czuczwar S.J. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model. Epilepsy Res. 76 (2007) 66-72
19. Luszczki J.J., Czernecki R., Wojtal K., Borowicz K.K., and Czuczwar S.J. Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J. Neural Transm. 115 (2008) 1485-1493
20. Luszczki J.J., Antkiewicz-Michaluk L., and Czuczwar S.J. Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol. 602 (2009) 298-305
21. Rogawski M.A., and Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42 (1990) 223-286
22. Twyman R.E., Rogers C.J., and Macdonald R.L. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann. Neurol. 25 (1989) 213-220
23. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., and Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 321 (1986) 864-866
24. White H.S., Woodhead J.H., Wilcox K.S., Stables J.P., Kupferberg H.J., and Wolf H.H. Discovery and preclinical development of antiepileptic drugs. In: Levy R.H., Mattson R.H., Meldrum B.S., and Perucca E. (Eds). Antiepileptic Drugs. fifth ed. (2002), Lippincott Williams & Wilkins, Philadelphia 36-48
25. Zejc A., Obniska J., Wilimowski M., Rutkowska M., Witkowska M., Barczynska J., Kedzierska-Gozdzik L., Wojewodzki W., Orzechowska-Juzwenko K., and Plawiak T. Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides. Pol. J. Pharmacol. Pharm. 42 (1990) 69-77